CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 980542593
- Phone
- (877) 237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-02 | Patel Priti Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-08-02 | DRACHMAN JONATHAN G President and CEO | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2022-08-02 | Cochener Donna General Counsel, SVP Legal | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-05-12 | SIMPSON TODD E Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-05-12 | PALEKAR ROHAN Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-05-12 | Noonberg Sarah B. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-05-12 | Lavelle Erin Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-05-12 | Babler Martin Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-05-12 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-05-02 | Patel Priti Chief Medical Officer | Sale | −5,538 | $1.22 | $7K | 6,462 |
| 2022-04-30 | Patel Priti Chief Medical Officer | Option exercise | +10,000 | 12,000 | ||
| 2022-04-30 | Patel Priti Chief Medical Officer | Option exercise · Restricted Stock Units | +10,000 | 10,000 | ||
| 2022-03-14 | Cochener Donna General Counsel, SVP Legal | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2022-03-02 | PALEKAR ROHAN Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-03-02 | Smith Sean Michael Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-02-01 | Walkey Carl Senior Vice President | Grant or award · Restricted Stock Units | +55,000 | 55,000 | ||
| 2022-02-01 | Patel Priti Chief Medical Officer | Grant or award · Restricted Stock Units | +70,000 | 70,000 | ||
| 2022-02-01 | Ho Robert Chief Financial Officer | Grant or award · Restricted Stock Units | +70,000 | 70,000 | ||
| 2021-08-25 | DRACHMAN JONATHAN G President and CEO | Purchase | +25,000 | $6.45 | $161K | 25,000 |
| 2021-08-25 | DRACHMAN JONATHAN G President and CEO | Purchase | +25,000 | $6.45 | $161K | 25,000 |
Page 7 of 8 · 158 trades